Study Name | Study Title | Study Type | Sponsor | Sponsor Type |
---|---|---|---|---|
VX14-661-109 | A Phase 3 Study to Evaluate the Efficacy and Safety of Ivacaftor and VX-661 in Combination With Ivacaftor in Subjects Aged 12 Years and Older With Cystic Fibrosis, Heterozygous for the F508del-CFTR Mutation | Clinical Trial | Vertex | Industry Sponsored |